OAKLAND, CA (US), July 2019 – A new clinical trial under way that is testing a therapy to treat brain metastases from breast cancers expressing high levels of a protein called HER2. Brain metastases are tumors in the brain that have spread from the original site of the
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
LONDON (UK), July 2019 — Scientists have identified a new type of cell called a hepatobiliary hybrid progenitor (HHyP) that forms during our early development in the womb.
ROCHESTER, MN (US), July 2019 ― A phase I clinical trial is the first research monitored by the Food and Drug Administration that demonstrates the potential of regenerative therapy for hypoplastic left heart syndrome (HLHS) through collecting, processing and injecting a
BOSTON, MA (US), July 2019 — A new study found that a transcription factor called Slug serves as “command central” for determining breast stem cell health, regulating both stem cell activity and repair of DNA damage.
WÜRZBURG (DE), July 2019 — Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers,” and thus modulate bone marrow niche properties and cell migration dynamics.
HEIDELBERG (DE), July 2019 — Patients with acute myeloid leukemia (AML) often relapse after apparently successful treatment. Leukemia stem cells that survive the therapy are responsible for the return of the disease.
MINNEAPOLIS, MN (US), July 2019 — New research at the University of Minnesota Medical School is the first to show that estrogen is essential to maintaining muscle stem cell health.
OKAZAKI CITY (JP), July 2019 — Stem cells self-renew and give rise to cells that are differentiated during development.
LOWELL, MA (US), July 2019 — Crushed or pulverized eggshells have dozens of practical uses — as a natural calcium supplement, a coffee sweetener, a treatment for minor skin irritations, a nontoxic abrasive
TOLEDO, OH (US), July 2019 — Scientists at the University of Toledo investigating improvements to a commonly used chemotherapy drug have discovered an entirely new class of cancer-killing agents that show promise in